These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 19028839)
1. Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling. Mukhopadhyay A; Saddoughi SA; Song P; Sultan I; Ponnusamy S; Senkal CE; Snook CF; Arnold HK; Sears RC; Hannun YA; Ogretmen B FASEB J; 2009 Mar; 23(3):751-63. PubMed ID: 19028839 [TBL] [Abstract][Full Text] [Related]
2. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. Saddoughi SA; Gencer S; Peterson YK; Ward KE; Mukhopadhyay A; Oaks J; Bielawski J; Szulc ZM; Thomas RJ; Selvam SP; Senkal CE; Garrett-Mayer E; De Palma RM; Fedarovich D; Liu A; Habib AA; Stahelin RV; Perrotti D; Ogretmen B EMBO Mol Med; 2013 Jan; 5(1):105-21. PubMed ID: 23180565 [TBL] [Abstract][Full Text] [Related]
3. Ceramide in the prostate. Dent P Cancer Biol Ther; 2013 Oct; 14(10):881-2. PubMed ID: 24025252 [TBL] [Abstract][Full Text] [Related]
4. Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment. Mukhopadhyay A; Tabanor K; Chaguturu R; Aldrich JV Cancer Biol Ther; 2013 Oct; 14(10):962-72. PubMed ID: 24025258 [TBL] [Abstract][Full Text] [Related]
5. Neuronal ceroid lipofuscinosis related ER membrane protein CLN8 regulates PP2A activity and ceramide levels. Adhikari B; De Silva B; Molina JA; Allen A; Peck SH; Lee SY Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):322-328. PubMed ID: 30453012 [TBL] [Abstract][Full Text] [Related]
6. Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer. Janghorban M; Farrell AS; Allen-Petersen BL; Pelz C; Daniel CJ; Oddo J; Langer EM; Christensen DJ; Sears RC Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9157-62. PubMed ID: 24927563 [TBL] [Abstract][Full Text] [Related]
7. Isoliensinine induces dephosphorylation of NF-kB p65 subunit at Ser536 via a PP2A-dependent mechanism in hepatocellular carcinoma cells: roles of impairing PP2A/I2PP2A interaction. Shu G; Zhang L; Jiang S; Cheng Z; Wang G; Huang X; Yang X Oncotarget; 2016 Jun; 7(26):40285-40296. PubMed ID: 27244888 [TBL] [Abstract][Full Text] [Related]
8. Expression of I2PP2A, an inhibitor of protein phosphatase 2A, induces c-Jun and AP-1 activity. Al-Murrani SW; Woodgett JR; Damuni Z Biochem J; 1999 Jul; 341 ( Pt 2)(Pt 2):293-8. PubMed ID: 10393085 [TBL] [Abstract][Full Text] [Related]
9. Interactions between the West Nile virus capsid protein and the host cell-encoded phosphatase inhibitor, I2PP2A. Hunt TA; Urbanowski MD; Kakani K; Law LM; Brinton MA; Hobman TC Cell Microbiol; 2007 Nov; 9(11):2756-66. PubMed ID: 17868381 [TBL] [Abstract][Full Text] [Related]
10. FTY720 induces apoptosis of M2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels. Chen L; Luo LF; Lu J; Li L; Liu YF; Wang J; Liu H; Song H; Jiang H; Chen SJ; Luo C; Li KK PLoS One; 2014; 9(7):e103033. PubMed ID: 25050888 [TBL] [Abstract][Full Text] [Related]
11. Ceramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo. Bharath LP; Ruan T; Li Y; Ravindran A; Wan X; Nhan JK; Walker ML; Deeter L; Goodrich R; Johnson E; Munday D; Mueller R; Kunz D; Jones D; Reese V; Summers SA; Babu PV; Holland WL; Zhang QJ; Abel ED; Symons JD Diabetes; 2015 Nov; 64(11):3914-26. PubMed ID: 26253611 [TBL] [Abstract][Full Text] [Related]
12. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. Chalfant CE; Rathman K; Pinkerman RL; Wood RE; Obeid LM; Ogretmen B; Hannun YA J Biol Chem; 2002 Apr; 277(15):12587-95. PubMed ID: 11801602 [TBL] [Abstract][Full Text] [Related]
13. A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function. Ruvolo PP; Clark W; Mumby M; Gao F; May WS J Biol Chem; 2002 Jun; 277(25):22847-52. PubMed ID: 11929874 [TBL] [Abstract][Full Text] [Related]
14. Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer. Farrell AS; Allen-Petersen B; Daniel CJ; Wang X; Wang Z; Rodriguez S; Impey S; Oddo J; Vitek MP; Lopez C; Christensen DJ; Sheppard B; Sears RC Mol Cancer Res; 2014 Jun; 12(6):924-39. PubMed ID: 24667985 [TBL] [Abstract][Full Text] [Related]
15. The interaction of SET and protein phosphatase 2A as target for cancer therapy. Dacol EC; Wang S; Chen Y; Lepique AP Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188578. PubMed ID: 34116173 [TBL] [Abstract][Full Text] [Related]
16. Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine. Chohan MO; Khatoon S; Iqbal IG; Iqbal K FEBS Lett; 2006 Jul; 580(16):3973-9. PubMed ID: 16806196 [TBL] [Abstract][Full Text] [Related]
17. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression. Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219 [TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Li M; Guo H; Damuni Z Biochemistry; 1995 Feb; 34(6):1988-96. PubMed ID: 7531497 [TBL] [Abstract][Full Text] [Related]
19. Ceramide produces apoptosis through induction of p27(kip1) by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells. Kim SW; Kim HJ; Chun YJ; Kim MY J Toxicol Environ Health A; 2010; 73(21-22):1465-76. PubMed ID: 20954073 [TBL] [Abstract][Full Text] [Related]